Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Synexus' Chief Medical Officer to discuss vaccine trial challenges at Washington event

Dr Glynis Neagle, Synexus' Chief Medical Officer will be discussing the challenges facing global vaccine trials at the World Vaccine Congress in Washington this week.

From AES - Accelerated Enrollment Solutions 11 Apr 2011

Viral infection likely to encourage pneumonia spread

Bacteria that cause pneumonia and meningitis are only able to spread when individuals are infected with flu, says a scientist reporting at the Society for General Microbiology's Spring Conference in Harrogate. The work could have implications for the management of influenza pandemics and could help reduce incidence of pneumococcal infections in very young children, who are more susceptible to disease.

11 Apr 2011

Almirall strengthens its respiratory franchise with a new generation of Chronic Obstructive Pulmonary Disease (COPD) treatment

Almirall strengthens its position in the respiratory field with a positive development progress of another New Chemical Entity (NCE). LAS190792 is a new dual long-acting Muscarinic Antagonist β2 Agonist (MABA), which combines two bronchodilator mechanisms in a single molecule for the treatment of COPD.

11 Apr 2011

Immunization does not increase emergency room visit in children with inherited disorders

Children with inborn errors of metabolism received vaccines on the same immunization schedule as did healthy infants, according to Kaiser Permanente Vaccine Study Center scientists who examined the Kaiser Permanente Northern California population. In addition, immunization was not associated with significant increases in emergency room visits or hospitalizations during the month following vaccination, according to Nicola Klein, MD, PhD, lead author of the study and co-director of the Kaiser Permanente Vaccine Study Center.

11 Apr 2011

Merck announces interim analysis from V710 Phase II/III trial in S. aureus infection

Merck, known as MSD outside the United States and Canada, and Intercell AG today announced that following a pre-specified interim analysis from the Phase II/III clinical trial evaluating V710, an investigational vaccine for the prevention of Staphylococcus aureus infection, the independent Data Monitoring Committee recommended suspension of enrollment.

11 Apr 2011

Gilenya can reduce risk of disability progression in patients with RRMS

A new analysis demonstrated that Gilenya reduced the risk of disability progression in patients with relapsing-remitting multiple sclerosis, regardless of treatment history. This analysis of the phase III two-year FREEDOMS study is one of 11 abstracts on Gilenya being presented at the 63rd annual meeting of the American Academy of Neurology.

11 Apr 2011

VIGILAIR air cleaning technology greatly reduces HAI in NICU: Study

VIGILAIR Systems, an industry leader in Ultraviolet Germicidal Irradiation technology was instrumental in a newly published, and first of its kind hospital study that demonstrated a dramatic reduction in patient Hospital Acquired Infections with the application of VIGILAIR® air cleaning technology in a Neonatal Intensive Care Unit.

11 Apr 2011

Research Roundup: The cost of medical errors; 'Unreasonable rate increases'

Health Affairs: The $17.1 Billion Problem: The Annual Cost Of Measurable Medical Errors - "The estimated total cost of measurable medical errors in the United States was $17.1 billion in 2008, which was 0.72 percent of the $2.391 trillion spent on health care," write the authors of this study that used an "an actuarial approach to measure the frequency and costs of measurable U.S. medical errors, identified through medical claims data."

8 Apr 2011

Some consumers left out of Anthem's delay to planned rate hikes

Although the insurer announced last month that it would delay a planned premium rate increase for about 600,000 policy holders, reports indicate that as many as 120,000 people will still experience the increases.

8 Apr 2011

Doctor files whistleblower retaliation lawsuit against Catholic Charities of Washington

Dr. Charles C. Briggs filed a whistleblower retaliation lawsuit today in D.C. Superior Court against Catholic Charities of the Archdiocese of Washington in connection with the organization's failure to rectify serious medical violations committed against patients at its clinics in Washington, D.C. and Langley Park, MD.

8 Apr 2011

FluCide nanoviricide drug reduces overall leukocytes in lung tissue of influenza model

NanoViricides, Inc. reports that post-infection treatment with its optimized FluCide drug candidates resulted in significant reduction in lung tissue presence of leukocytes, and in particular, that of eosinophils in a lethal influenza infection animal model.

8 Apr 2011

Democratic Congresswoman highlights threat climate change poses to public health

Rep. Lois Capps (D-Calif.) "called climate change a bigger public health threat than AIDS, malaria and pandemic flu" before a vote on Wednesday on a bill aimed at thwarting Environmental Protection Agency climate regulations, The Hill's "E2-Wire" blog reports.

8 Apr 2011

Study: DBS surgery allows 77% of patients to stop anti-tremor medication use

Deep brain stimulation, a surgical procedure to suppress faulty nerve signals, allowed 77 percent of patients to stop the medications used to treat their essential tremors within one year following the surgery, University of South Florida researchers report.

8 Apr 2011

AstraZeneca's vandetanib receives FDA approval in medullary thyroid cancer

AstraZeneca today announced that the U.S. Food and Drug Administration approved the orphan drug vandetanib for the treatment of medullary thyroid cancer that cannot be removed by surgery or that has spread to other parts of the body.

7 Apr 2011

Top 10 global pharmaceutical company, Medicago sign deal to develop non-influenza vaccine

Medicago Inc., a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that it has entered into a research collaboration agreement for the development of a non-influenza vaccine candidate with a top 10 global pharmaceutical company.

7 Apr 2011

Parents and schools may contribute to childhood obesity

Two of the biggest influences on children — parents and schools — may unintentionally contribute to childhood obesity. That's the observation of Susan Terwilliger, clinical associate professor in the Decker School of Nursing at Binghamton University, who studies the problem.

7 Apr 2011

Seattle Genetics presents SGN-35 study data in Hodgkin lymphoma at EBMT meeting

Seattle Genetics, Inc. today announced that data from a case series of Hodgkin lymphoma patients receiving brentuximab vedotin following allogeneic stem cell transplant were presented in an oral session at the European Group for Blood and Marrow Transplantation Annual Meeting in Paris, France.

7 Apr 2011

Quest Diagnostics Simplexa molecular test receives bronze award for best new product

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, today announced that the Simplexa™ molecular test on the 3M™ Integrated Cycler was honored with a bronze award for best new science and medical diagnostic product during the 2011 Edison Awards gala ceremony last night in New York City.

From Quest Diagnostics 7 Apr 2011

U.S. Marshals, FDA seize $6 million worth Triad antiseptic products

U.S. Marshals, at the request of the U.S. Food and Drug Administration, today seized more than $6 million in products distributed by Triad Group Inc., at the company's facility in Hartland, Wis.

7 Apr 2011

AstraZeneca receives FDA approval for vandetanib to treat medullary thyroid cancer

The U.S. Food and Drug Administration today approved vandetanib to treat adult patients with late-stage (metastatic) medullary thyroid cancer who are ineligible for surgery and who have disease that is growing or causing symptoms.

7 Apr 2011

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Synexus' Chief Medical Officer to discuss vaccine trial challenges at Washington event

Viral infection likely to encourage pneumonia spread

Almirall strengthens its respiratory franchise with a new generation of Chronic Obstructive Pulmonary Disease (COPD) treatment

Immunization does not increase emergency room visit in children with inherited disorders

Merck announces interim analysis from V710 Phase II/III trial in S. aureus infection

Gilenya can reduce risk of disability progression in patients with RRMS

VIGILAIR air cleaning technology greatly reduces HAI in NICU: Study

Research Roundup: The cost of medical errors; 'Unreasonable rate increases'

Some consumers left out of Anthem's delay to planned rate hikes

Doctor files whistleblower retaliation lawsuit against Catholic Charities of Washington

FluCide nanoviricide drug reduces overall leukocytes in lung tissue of influenza model

Democratic Congresswoman highlights threat climate change poses to public health

Study: DBS surgery allows 77% of patients to stop anti-tremor medication use

AstraZeneca's vandetanib receives FDA approval in medullary thyroid cancer

Top 10 global pharmaceutical company, Medicago sign deal to develop non-influenza vaccine

Parents and schools may contribute to childhood obesity

Seattle Genetics presents SGN-35 study data in Hodgkin lymphoma at EBMT meeting

Quest Diagnostics Simplexa molecular test receives bronze award for best new product

U.S. Marshals, FDA seize $6 million worth Triad antiseptic products

AstraZeneca receives FDA approval for vandetanib to treat medullary thyroid cancer

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Newsletters you may be interested in